|
N.V. Bagisheva, A.V. Mordyk, I.A. Viktorova, M.V. Moiseeva, S.V. Sitnikova, A.R. Aroyan
New-onset pulmonary tuberculosis in a patient with chronic obstructive pulmonary disease and coronary artery disease, angina pectoris: treatment options
|
№5 / 2022
|
|
E.Yu. Trushina, E.M. Kostina
Markers of eosinophilic and neutrophilic inflammation of respiratory tract in patients with non-allergic bronchial asthma and chronic obstructive pulmonary disease
|
№5 / 2021
|
|
N.V. Bagisheva (1), A.V. Mordyk (1), I.A. Viktorova (1), K.I. Nesterova (1), V.V. Goltyapin (2), A.R. Aroyan (1), S.A. Rudenko (3), N.V. Shirinskaya (4)
Factor analysis of medical risk factors for the development of an unfavorable outcome of tuberculosis treatment in comorbid patients
|
№5 / 2021
|
|
L.V. Vasilyeva (1), E.N. Bezzubtseva (1), E.F. Evstratova (1), E.V. Gosteva (1), I.B. Zubkova (2)
Clinical significance of genetic and inflammatory markers of bone metabolism in patients with chronic obstructive pulmonary disease and osteoporosis
|
№5 / 2021
|
|
A.I. Sinopalnikov
Bronchodilator therapy for COPD: a 20-year road
|
№5 / 2021
|
|
N.A. Karoli, A.P. Rebrov
Beta-blockers in patients with chronic obstructive pulmonary disease: for whom, when, how?
|
№5 / 2020
|
|
I.V. Leshchenko (1, 2), V.E. Evdokimov (1)
The place of nebulizer therapy in clinical practice
|
№5 / 2020
|
|
A.A. Vizel (1), I.Yu. Vizel (1, 2), I.N. Salakhova (1), A.R. Vafina (1)
Adherence in bronchial asthma and chronic obstructive pulmonary disease: from a problem to a solution
|
№5 / 2019
|
|
L.V. Vasilyeva, E.F. Evstratova, V.A. Nikitin, M.N. Latysheva
Pathogenetic mechanisms for the treatment of the lumbar pain syndrome caused by osteoporosis of mixed genesis in patients with chronic obstructive pulmonary disease
|
№5 / 2019
|
|
A.I. Sinopalnikov
Antibiotics and community-acquired low respiratory tract infections. Who for? What preparation?
|
№5 / 2019
|
|
Yu.G. Belotserkovskaya, A.I. Sinopalnikov, A.G. Romanovskikh, I.P. Smirnov
The concept of controlling chronic obstructive pulmonary disease
|
№5 / 2019
|
|
A.V. Emelyanov, E.V. Leshenkova, G.R. Sergeeva
Inhaled glucocorticosteroids in the treatment of chronic obstructive pulmonary disease: the debate continues
|
№5 / 2019
|
Русский
